PIM
EXAS

Plato Investment Management’s Exact Sciences EXAS Stock Holding History

Plato Investment Management’s Portfolio EXAS Stock Details EXAS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q4 		– Sell
-7,856
Closed -$535K – 593
2024
Q3 		$535K Sell
7,856
-262
-3% -$14.8K 0.04% 311
2024
Q2 		$343K Sell
8,118
-3,629
-31% -$200K 0.03% 299
2024
Q1 		$811K Buy
11,747
+11,403
+3,315% +$721K 0.08% 227
2023
Q4 		$25.4K Buy
+344
New +$22.5K 0.03% 295

Other funds holding EXAS

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $145B AUM 22.78% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Plato Investment Management's EXAS Position: Q4 2024 in Review

Plato Investment Management sold out of Exact Sciences (EXAS) in Q4 2024, closing a stake of 7,856 shares — an estimated $535K sold.

Plato Investment Management first reported a position in EXAS in Q4 2023 and held it in 4 quarters. The position peaked at $811K in Q1 2024. 594 funds tracked by Wall St. Rank hold EXAS as of Q4 2024.

  • Plato Investment Management reported no remaining Exact Sciences position as of Q4 2024 after selling out during the quarter.
  • Plato Investment Management sold 7,856 Exact Sciences shares in Q4 2024, an estimated $535K.
  • Plato Investment Management first reported a position in Exact Sciences in Q4 2023 and held it in 4 quarters.
  • Plato Investment Management's Exact Sciences position peaked at $811K in Q1 2024.
  • 594 funds tracked by Wall St. Rank held Exact Sciences as of Q4 2024.

Based on Plato Investment Management's 13F filing for Q4 2024, filed 6 Feb 2025.